The order carried out as a part of the project titled:
ARG: PRE-CLINICAL AND CLINICAL DEVELOPMENT OF AN ARGINASE INHIBITOR FOR CANCER IMMUNOTHERAPY (POIR.01.01.01-00-415/17)
co-financed by the European Union Funds and because of the competitiveness principle. We hereby look for Contractor ready to perform the service:
Preparation of drug development plan (DDP) for OATD-02 compound and clinical trial protocol synopsis for a Phase 1 evaluation of OATD-02, as a single agent and in combination molecularly targeted agents therapy, in patients with advanced/metastatic solid tumors.